http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107362372-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2017-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107362372-B |
| titleOfInvention | Use application of the CRISPR technology in coronary atherosclerotic heart disease |
| abstract | The present invention provides a kind of method that microRNA-8086 gene is specifically knocked out using CRISPR-Cas9, the method are as follows: (1) constructs Cas9 expression vector；(2 building sgRNA expression vectors;(3) Cas9, sgRNA- are mixed into mixed liquor, inject mammal fertilized eggs, realized the purpose of the gene site-directed knockout of microRNA-8086. |
| priorityDate | 2017-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.